CHRNHealthcareNano-Cap

EKSO BIONICS HOLDINGS, INC. Insider Trading Activity

Every SEC Form 4 insider transaction reported for EKSO BIONICS HOLDINGS, INC. (CHRN), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are CHRN insiders buying or selling?

EKSO BIONICS HOLDINGS, INC. insiders reported 7 open-market buys ($1.5M) and 33 sells ($615.1K) across 40 Form 4 filings — a net buying position of $905.7K.

Source: SEC EDGAR Form 4

Key Statistics (as of Mar 20, 2026)

Total Form 4 filings
40
SEC EDGAR
Insider filers
8
Insider buys (7)
$1.5M
Insider sells (33)
$615.1K

Insider sentiment

Net buying

Net insider flow of $905.7K in net buying.

Recent CHRN insider transactions

DateInsiderRoleTypeSharesPriceValue
Mar 20, 2026Jason C JonesChief Operating OfficerPurchase1.3K$11.85$15.5K
Mar 20, 2026Jerome WongChief Financial OfficerPurchase1.3K$11.85$15.5K
Feb 20, 2026ASHER DANIEL10% OwnerPurchase15.5K$12.30$191.2K
Feb 19, 2026ASHER DANIEL10% OwnerPurchase1.2K$9.60$11.5K
Feb 17, 2026ASHER DANIEL10% OwnerPurchase102.0K$9.51$970.1K
Jan 7, 2026Jason C JonesChief Operating OfficerSale1.3K$9.25$12.2K
Dec 10, 2025Jason C JonesChief Operating OfficerSale270$4.70$1.3K
Dec 10, 2025Jerome WongChief Financial OfficerSale1.2K$4.70$5.8K
Nov 12, 2025Jerome WongChief Financial OfficerSale11.3K$4.80$54.2K
Nov 12, 2025Jason C JonesChief Operating OfficerSale9.7K$4.80$46.7K
Nov 12, 2025Scott G. DavisCEOSale23.3K$4.80$111.9K
Mar 14, 2024Corinna LathanDirectorPurchase13.7K$1.13$15.5K
Aug 19, 2023Scott G. DavisPresident & COOSale37.4K$1.00$37.3K
Aug 19, 2023Jerome WongChief Financial OfficerSale12.8K$1.00$12.7K
May 26, 2023SHERMAN STEVENExecutive ChairSale45.7K$1.44$65.9K
May 17, 2023Jason C JonesChief Operating OfficerSale3.4K$1.57$5.4K
Dec 8, 2022SHERMAN STEVENExecutive ChairSale10.6K$1.28$13.5K
Nov 23, 2022SHERMAN STEVENCEO & ChairmanSale5.8K$1.26$7.3K
Nov 17, 2022Jason C JonesSenior VP Product DevelopmentSale782$1.28$1.0K
Nov 17, 2022Jerome WongChief Financial OfficerSale723$1.28$927.25
Oct 26, 2022SHERMAN STEVENCEO & ChairmanSale5.9K$1.29$7.6K
Sep 26, 2022SHERMAN STEVENCEO & ChairmanSale6.0K$1.75$10.6K
Sep 2, 2022Jason C JonesSenior VP Product DevelopmentSale5.9K$2.31$13.6K
Aug 23, 2022SHERMAN STEVENCEO & ChairmanSale5.6K$2.20$12.3K
Aug 4, 2022Jerome WongInterimChief Financial OfficerSale1.7K$1.80$3.0K

Showing the 25 most recent of 40 Form 4 filings for EKSO BIONICS HOLDINGS, INC..

Most active CHRN insiders

  • SHERMAN STEVEN14 filings
  • Jason C Jones9 filings
  • Jerome Wong7 filings
  • ASHER DANIEL3 filings
  • Scott G. Davis3 filings

Ask anything about CHRN insider activity

Use Trabud's AI agent to query EKSO BIONICS HOLDINGS, INC.'s Form 4 history in plain English — "Show me CHRN CEO purchases this year" or compare it against any other ticker.

Open the AI agent

CHRN insider trading FAQ

Are EKSO BIONICS HOLDINGS, INC. insiders buying or selling?

Across 40 SEC Form 4 filings, EKSO BIONICS HOLDINGS, INC. (CHRN) insiders reported 7 open-market purchases totaling $1.5M and 33 sales totaling $615.1K. That is a net buying position of $905.7K.

How many insiders trade CHRN stock?

8 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for EKSO BIONICS HOLDINGS, INC.. The most recent filing was accepted on Mar 20, 2026.

Where does Trabud get CHRN insider trading data?

All CHRN insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content